Literature DB >> 1370410

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.

D M Baume1, M J Robertson, H Levine, T J Manley, P W Schow, J Ritz.   

Abstract

Human natural killer (NK) cells can be subdivided into two populations based on the density of cell surface CD56 antigen. The great majority (approximately 90%) of NK cells express CD56 at low levels (the CD56dim phenotype), whereas a small NK cell subset (approximately 10%) exhibits approximately fivefold greater density of surface CD56. Exposure to exogenous interleukin 2 (IL 2) induces tenfold greater proliferation of CD56bright cells compared to CD56dim lymphocytes, even though both subsets constitutively express similar levels of intermediate affinity IL 2 receptor (IL 2R) p75 chains. Incubation with IL 2 alone or irradiated target cells alone could induce expression of the IL 2R p55 chain by both CD56bright and CD56dim NK cells; a combination of both stimuli was most effective. IL 2R p55 induction was evident after co-culture of NK cells with both NK-sensitive and NK-resistant cell lines or with antibody-coated target cells. Activation of NK cells with IL 2 plus target cells resulted in enhanced proliferation compared to activation with IL 2 alone; target cells alone did not induce significant proliferation. Although both NK cell subsets appeared to express high-affinity IL 2R p75/p55 heterodimers after stimulation with target cells and IL 2, proliferation of CD56dim cells remained minimal after such activation; activated CD56dim cells consistently demonstrated less proliferation to IL 2 than did resting CD56bright cells. In contrast, CD56bright NK cells exhibited even greater proliferation after stimulation with target cells. Almost all CD56dim NK cells expressed CD16 (Fc gamma R III) as well as the NK zeta chain, whereas less than 50% of CD56bright cells express either CD16 or zeta. CD56bright and CD56dim lymphocytes, thus, appear to represent distinct subpopulations of NK cells with different functional activities. Unlike CD56bright cells, CD56dim NK cells do not proliferate optimally to IL 2, even after the latter have been stimulated to express both IL 2R p55 and IL 2R p75. Efficient proliferation of CD56dim NK cells may, thus, require additional or alternative signals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370410     DOI: 10.1002/eji.1830220102

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

1.  Regulation of CR3 (CD11b/CD18)-dependent natural killer (NK) cell cytotoxicity by tumour target cell MHC class I molecules.

Authors:  V Vĕtvicka; M Hanikýrová; J Vĕtvicková; G D Ross
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents.

Authors:  S Muto; V Vĕtvicka; G D Ross
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

3.  A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Authors:  W E Carson; T A Fehniger; S Haldar; K Eckhert; M J Lindemann; C F Lai; C M Croce; H Baumann; M A Caligiuri
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.

Authors:  Jordan S Orange; Sumita Roy-Ghanta; Emily M Mace; Saumya Maru; Gregory D Rak; Keri B Sanborn; Anders Fasth; Rushani Saltzman; Allison Paisley; Linda Monaco-Shawver; Pinaki P Banerjee; Rahul Pandey
Journal:  J Clin Invest       Date:  2011-03-07       Impact factor: 14.808

5.  Ascorbic Acid Promotes KIR Demethylation during Early NK Cell Differentiation.

Authors:  Cheng-Ying Wu; Bin Zhang; Hansol Kim; Stephen K Anderson; Jeffrey S Miller; Frank Cichocki
Journal:  J Immunol       Date:  2020-08-05       Impact factor: 5.422

Review 6.  Biology and clinical impact of human natural killer cells.

Authors:  Sherif S Farag; Jeffrey B VanDeusen; Todd A Fehniger; Michael A Caligiuri
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 7.  The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Authors:  Bree Foley; Martin Felices; Frank Cichocki; Sarah Cooley; Michael R Verneris; Jeffrey S Miller
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

8.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2.

Authors:  M A Caligiuri; C Murray; M J Robertson; E Wang; K Cochran; C Cameron; P Schow; M E Ross; T R Klumpp; R J Soiffer
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin.

Authors:  P André; O Spertini; S Guia; P Rihet; F Dignat-George; H Brailly; J Sampol; P J Anderson; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

10.  The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.

Authors:  Tim D Holmes; Ram Vinay Pandey; Eric Y Helm; Heinrich Schlums; Hongya Han; Tessa M Campbell; Theodore T Drashansky; Samuel Chiang; Cheng-Ying Wu; Christine Tao; Moneef Shoukier; Eva Tolosa; Sandra Von Hardenberg; Miao Sun; Christian Klemann; Rebecca A Marsh; Colleen M Lau; Yin Lin; Joseph C Sun; Robert Månsson; Frank Cichocki; Dorina Avram; Yenan T Bryceson
Journal:  Sci Immunol       Date:  2021-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.